Published in Drug Week, April 1st, 2005
Pegasys combination therapy is the only regimen FDA-approved for hepatitis C treatment in patients with HIV, according to Roche.
Pegasys was approved in 2002 by the FDA for use alone and in combination with Copegus for the treatment of adults with chronic hepatitis C.
"For the first time, the 300,000 Americans who are co-infected with hepatitis C and HIV have an FDA-approved hepatitis C treatment option....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.